Literature DB >> 32511106

The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update.

.   

Abstract

Mesh：

Substances：

Year:  2020        PMID： 32511106     DOI： 10.1097/ADM.0000000000000633

Source DB:  PubMed          Journal:  J Addict Med        ISSN： 1932-0620            Impact factor:   3.702


× No keyword cloud information.
  23 in total

1.  Demographic and Geospatial Analysis of Buprenorphine and Methadone Prescription Rates.

Authors:  Nicholas J Peterman; Peggy Palsgaard; Aksal Vashi; Tejal Vashi; Bradley D Kaptur; Eunhae Yeo; Warren Mccauley
Journal:  Cureus       Date:  2022-05-30

2.  Management of opioid use disorder, opioid withdrawal, and opioid overdose prevention in hospitalized adults: A systematic review of existing guidelines.

Authors:  Susan L Calcaterra; Richard Bottner; Marlene Martin; Honora Englander; Zoe M Weinstein; Melissa B Weimer; Eugene Lambert; Matthew V Ronan; Sergio Huerta; Tauheed Zaman; Monish Ullal; Alyssa F Peterkin; Kristine Torres-Lockhart; Megan Buresh; Meghan T O'Brien; Hannah Snyder; Shoshana J Herzig
Journal:  J Hosp Med       Date:  2022-07-26       Impact factor: 2.899

3.  Patients' experiences of continued treatment with extended-release naltrexone: a Norwegian qualitative study.

Authors:  Anne Marciuch; Ida Halvorsen Brenna; Bente Weimand; Kristin Klemmetsby Solli; Lars Tanum; Bente K Røstad; Bente Birkeland
Journal:  Addict Sci Clin Pract       Date:  2022-07-18

4.  Attitudes toward opioid use disorder pharmacotherapy among recovery community center attendees.

Authors:  Lauren A Hoffman; Corrie L Vilsaint; John F Kelly
Journal:  J Subst Abuse Treat       Date:  2021-05-08

5.  Maternal Complications and Prescription Opioid Exposure During Pregnancy: Using Marginal Structural Models.

Authors:  Xuerong Wen; Shuang Wang; Adam K Lewkowitz; Kristina E Ward; Erin Christine Brousseau; Kimford J Meador
Journal:  Drug Saf       Date:  2021-10-05       Impact factor: 5.606

6.  Oxytocin Receptor Activation Rescues Opioid-Induced Respiratory Depression by Systemic Fentanyl in the Rat.

Authors:  Allison Doyle Brackley; Glenn M Toney
Journal:  J Pharmacol Exp Ther       Date:  2021-05-14       Impact factor: 4.402

7.  Quality of Buprenorphine Care for Insured Adults With Opioid Use Disorder.

Authors:  Kelly E Anderson; Brendan Saloner; Julia Eckstein; Christine E Chaisson; Sarah H Scholle; Lauren Niles; Sydney Dy; G Caleb Alexander
Journal:  Med Care       Date:  2021-05-01       Impact factor: 3.178

8.  Commentary on Hill et al.: Breaking down barriers-increasing access to lifesaving opioid use disorder medications to save lives.

Authors:  Michael S Toce; Scott E Hadland
Journal:  Addiction       Date:  2021-01-06       Impact factor: 7.256

9.  Medication for Addiction Treatment and Postpartum Health Care Utilization Among Pregnant Persons With Opioid Use Disorder.

Authors:  Katherine A Ahrens; Carole A McBride; Alane O'Connor; Marjorie C Meyer
Journal:  J Addict Med       Date:  2022 Jan-Feb 01       Impact factor: 3.702

10.  Do out-of-pocket costs influence retention and adherence to medications for opioid use disorder?

Authors:  Christopher Dunphy; Cora Peterson; Kun Zhang; Christopher M Jones
Journal:  Drug Alcohol Depend       Date:  2021-05-21       Impact factor: 4.852
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.